Patents by Inventor Matthew Shurtleff

Matthew Shurtleff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLING LYSOSOMAL TARGETING ANTIBODY CONJUGATES
    Publication number: 20260224714
    Abstract: The present disclosure provides conjugates comprising a moiety that targets a lysosomal targeting molecule, a linker, and an antibody that specifically binds a cell surface target molecule or extracellular target molecule that is targeted for degradation.
    Type: Application
    Filed: January 17, 2024
    Publication date: August 6, 2026
    Inventors: Nicholas Lind, Tao Chen, Christos Kougentakis, Jason G. Lewis, Matthew Shurtleff, Steven Staben, Eric D. Turtle, Richard Yau, Shuai Zheng, Thomas-Toan Tran
  • LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF AUTOANTIBODIES
    Publication number: 20260224719
    Abstract: The present disclosure provides bifunctional molecules including a moiety that targets a lysosomal targeting molecule, a linker, and a polypeptide that specifically binds a extracellular target molecule such as an antibody that is targeted for degradation.
    Type: Application
    Filed: January 17, 2024
    Publication date: August 6, 2026
    Inventors: Darrin Anthony Lindhout, Tao Chen, Richard Glynne, Jeffrey Iwig, Jason G. Lewis, Diana Li, Nicholas Lind, Matthew Shurtleff, Steven Staben, Sarah Michelle Totten, Eric D. Turtle